Phase 1b trial of anti-EGFR antibody JMT101 and Osimertinib in EGFR exon 20 insertion-positive non-small-cell lung cancer.
Zhao S, Zhuang W, Han B, Song Z, Guo W, Luo F, Wu L, Hu Y, Wang H, Dong X, Jiang D, Wang M, Miao L, Wang Q, Zhang J, Fu Z, Huang Y, Xu C, Hu L, Li L, Hu R, Yang Y, Li M, Yang X, Zhang L, Huang Y, Fang W.
Zhao S, et al. Among authors: hu y, hu l, hu r.
Nat Commun. 2023 Jun 12;14(1):3468. doi: 10.1038/s41467-023-39139-4.
Nat Commun. 2023.
PMID: 37308490
Free PMC article.
Clinical Trial.